PharmaShots

CXO TALKS

PharmaShots CXO Talks | A Conversation with Liz Benditt, Founder & CEO, The Balm Box

Shots: • From navigating six cancer diagnoses to building a mission-driven brand, Liz Benditt turned her personal journey into purpose by founding The Balm Box, a company designed to make treatment days a little less overwhelming and a lot more thoughtful for patients and caregivers alike. • In this CXO Talks episode, we dive into…

4 days ago

CXO Talks: Vikas Sharma Reveals QurAlis’ Bold Vision for the Future of Neuroscience

In this episode of CXO Talks, PharmaShots speaks with Vikas Sharma, Chief Business Officer at QurAlis, a biotech company leading the development of precision medicines for neurodegenerative diseases Vikas discusses the company’s FlexASO platform, a next-generation RNA-targeting technology that tackles the root causes of neurological diseases Vikas also highlights QurAlis’ lead candidates, QRL-201 and QRL-101,…

November 10, 2025

CXO Talks: Josh Wittner from Gene By Gene in a Riveting Conversation with PharmaShots

Shots: In this captivating episode of the CXO Talks Podcast, PharmaShots sits down with Josh Wittner, President, North America at Gene By Gene, to explore the company’s evolution and impact in the field of genetic testing Gene By Gene, a leading commercial genetic testing company, delivers cutting-edge genetic data services spanning a broad range of…

October 13, 2025

CXO Talks: Rick Modi from Affinia Therapeutics in a Stirring Dialogue Exchange with PharmaShots

Shots: In this episode of the CXO Talks podcast, PharmaShots speaks with Rick Modi, CEO at Affinia Therapeutics Driven by cutting-edge innovation, Affinia is pioneering and re-imagining adeno-associated virus serotype 9 (AAV9), a gene therapy delivery method for conditions affecting cardiac muscle, skeletal muscle, and the central nervous system Rick articulates the diagnostic and therapeutic…

September 8, 2025

CXO Talks: Thomas Chalberg & Annahita Keravala from Genascence in a Candid Conversation with PharmaShots

Shots: PharmaShots speaks with Thomas Chalberg, Founder and CEO of Genascence Corporation, and Annahita Keravala, Founder and CSO of Genascence Corporation Thomas and Annahita speak eloquently about Genascence's current lead program, GNSC-001, for osteoarthritis of the knee, and shed light on the unmet medical needs in the disease The duo highlighted the safety and tolerability…

August 11, 2025

CXO Talks: Tim O’Connell from Emtelligent in a Striking Conversation with PharmaShots

Shots: In this episode of the CXO Talks podcast, PharmaShots spoke with Tim O’Connell, CEO of Emtelligent, a next-generation medical AI company Tim highlights Emtelligent’s inspiring journey to becoming a leader in a clinical-grade NLP company focused on transforming unstructured data to actionable insights at an enterprise scale Emtelligent leverages the power of medical records…

June 9, 2025

CXO Talks: Colin Banas from DrFirst in an Illuminating Conversation with PharmaShots

In the CXO Talks podcast, PharmaShots engaged in a riveting dialogue exchange with Colin Banas, Chief Medical Officer at DrFirst. Colin highlights the evolution of DrFirst from becoming a leader in the e-prescribing space to an end-to-end medication management company Colin talks about its collaborators, Wise Hospice Options, achieving a new milestone by reducing the…

May 12, 2025

CXO Talks: Ali Jannati from Linus Health in a Stimulating Dialogue Exchange with PharmaShots

In the CXO Talks podcast, PharmaShots spoke with Ali Jannati, Director of Cognitive Science at Linus Health. Ali eloquently highlighted Linus’ journey to becoming a leader in digital brain health through its innovative digital cognitive assessment platform He emphasized the importance of digital biomarkers in evaluating brain function by capturing subtle nuances and response latencies,…

April 14, 2025

CXO Talks: Heba Nowyhed from Arcellx in a Candid Conversation with PharmaShots

CAR T-cell therapies hold a promising foothold in addressing unmet healthcare needs. Arcellx, a clinical-stage biotech company, is steadfastly exploring the potential of cell therapy in RRMM and generalized myasthenia gravis patients with its lead asset anito-cel. During presentations at ASH, anito-cel demonstrated no delayed neurotoxicity in both P-1 and pivotal P-II clinical trials for multiple myeloma.…

March 28, 2025

CXO Talks: Cary Claiborne from Adial Pharmaceuticals in a Stimulating Dialogue Exchange with PharmaShots

Welcome to the sixth episode of CXO Talks, featuring Cary Claiborne, CEO of Adial Pharmaceuticals a clinical-stage biopharmaceutical company dedicated to developing therapies for the treatment and prevention of addiction and related disorders. Taking a walk down memory lane, Cary shares the inspiration behind founding Adial Pharmaceuticals. He recounts how an early study at the…

December 9, 2024